Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Shuo-Guo Xu"'
Autor:
Hong-Yu Luo, Shuo-Guo Xu, Li-Chen Gao, Hui-Zhi Long, Zi-Wei Zhou, Feng-Jiao Li, Shang-Ming Dai, Jin-Da Hu, Yu Su, Yan Cheng
Publikováno v:
Drugs in R&D, Vol 24, Iss 1, Pp 81-87 (2024)
Abstract Background Potassium bismuth citrate is a gastric mucosal protector and a key drug for treating peptic ulcers. Objective To evaluate the pharmacokinetic characteristics and safety of 120-mg bismuth potassium citrate formulations administered
Externí odkaz:
https://doaj.org/article/baf0293783834770ba3a943628c58a29
Autor:
Shang-Ming Dai, Feng-Jiao Li, Hui-Zhi Long, Zi-Wei Zhou, Hong-Yu Luo, Shuo-Guo Xu, Li-Chen Gao
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Malignant tumor is a major killer that seriously endangers human health. At present, the methods of treating tumors include surgical resection, chemotherapy, radiotherapy and immunotherapy. However, the survival rate of patients is still very low due
Externí odkaz:
https://doaj.org/article/9c13c1004061422fbcce95ca95be6443
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The activation of ferroptosis is a new effective way to treat drug-resistant solid tumors. Ferroptosis is an iron-mediated form of cell death caused by the accumulation of lipid peroxides. The intracellular imbalance between oxidant and antioxidant d
Externí odkaz:
https://doaj.org/article/f8d6ed1fba1a4a5ca5b0d3345a21dd21
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
Alzheimer’s disease (AD), the most common type of senile dementia, includes the complex pathogenesis of abnormal deposition of amyloid beta-protein (Aβ), phosphorylated tau (p-tau) and neuroimmune inflammatory. The neurodegenerative process of AD
Externí odkaz:
https://doaj.org/article/d6ab2b8c9fcc410581ef6031be4f2e73
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Inflammation is a protective response of the body to an irritant. When an inflammatory response occurs, immune cells are recruited to the injury, eliminating the irritation. The excessive inflammatory response can cause harm to the organism. Inflamma
Externí odkaz:
https://doaj.org/article/041d7f1168794196962635f663e8ac08
Autor:
Hong-Yu Luo, Li-Chen Gao, Hui-Zhi Long, Zi-Wei Zhou, Shuo-Guo Xu, Feng-Jiao Li, Hong-Li Li, Yan Cheng, Cai-Xia Li, Xing-Yu Peng, Liang Li, Ran Chen, Ping Deng
Publikováno v:
European Journal of Clinical Pharmacology. 79:663-670
Autor:
Hong-Yu, Luo, Zhen-Jiang, Yao, Hui-Zhi, Long, Zi-Wei, Zhou, Shuo-Guo, Xu, Feng-Jiao, Li, Yan, Cheng, Dan-Dan, Wen, Ping, Deng, Yue-Qing, Guan, Li-Chen, Gao
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 61:129-138
To evaluate the pharmacokinetics (PK), safety, and bioequivalence of two formulations of apixaban in healthy Chinese subjects under fasting and fed conditions.A single-center, randomized, open, single-dose, two-period crossover PK study was carried o
Autor:
Hong-Yu Luo, Hui-Zhi Long, Zi-Wei Zhou, Shuo-Guo Xu, Feng-Jiao Li, Yan Cheng, Dan-Dan Wen, Ping Deng, Li-Chen Gao
Publikováno v:
Drugs in R&D. 22:311-320
Cloperastine is a pivotal antibechic widely prescribed to treat cough caused by respiratory diseases. The present trial evaluated the pharmacokinetics (PK), bioequivalence (BE) and safety effects of the generic test (T) tablet of cloperastine after s
Autor:
Hong‐Yu Luo, Hui‐Zhi Long, Zi‐Wei Zhou, Shuo‐Guo Xu, Feng‐Jiao Li, Yan Cheng, Dan‐Dan Wen, Ping Deng, Li‐Chen Gao
Publikováno v:
Clinical pharmacology in drug developmentReferences.
The purpose of this trial was to evaluate the pharmacokinetics (PK), bioequivalence (BE), and safety of 2 preparations of hydroxychloroquine (200-mg tablet) under fasting and fed conditions. A total of 180 subjects (fasting condition: n = 80; fed con
Autor:
Li-Chen Gao, Hong-Yu Luo, Hui-Zhi Long, Zi-Wei Zhou, Shuo-Guo Xu, Feng-Jiao Li, Yan Cheng, Dan-Dan Wen, Ping Deng
Background: Cloperastine is a preferred pivotal antibechic drug, mainly used for the cough caused by respiratory diseases. Previous studies have proved that it is effective and safe in the patients. Methods: The present phase I trial was designed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a34130080b59d6397b434972d86c4285
https://doi.org/10.21203/rs.3.rs-1493719/v1
https://doi.org/10.21203/rs.3.rs-1493719/v1